ESC Premium Access

Mechanisms of cardiovascular impact of SGLT2 inhibitors.

Congress Presentation

About the speaker

Professor Bart Staels

Lille Cedex (France)
1 presentation
0 follower

3 more presentations in this session

Epigenetic signatures and cardiovascular risk in diabetes.

Speaker: Professor F. Cosentino (Stockholm, SE)


Use of incretin-based therapies.

Speaker: Professor L. Ryden (Stockholm, SE)


SGLT2 inhibitors and alteration of substrate metabolism.

Speaker: Professor E. Ferrannini (Pisa, IT)


Access the full session

How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?

Speakers: Professor B. Staels, Professor F. Cosentino, Professor L. Ryden, Professor E. Ferrannini

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb